MedPath

The Alouette Test in Parkinson Disease

Completed
Conditions
Parkinson Disease
Interventions
Other: Alouette test (reading test)
Registration Number
NCT03958175
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Reading disorders in Parkinson's Disease (PD) are poorly evaluated due to the lack of validated tests to screen for them. They are often attributed to hand tremors associated with the disease. In this study, the investigating team evaluated the "alouette test" validated for dyslexia screening, in PD by comparing the results to healthy patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
38
Inclusion Criteria
  • Patients with Parkinson's Disease
  • Montreal Cognitive Assessment (MoCA) test > 20
Read More
Exclusion Criteria
  • Patient's with supranuclear Palsy
  • Other neurologic disease
  • Any ophthalmologic disease
  • Presence of a nystagmus
  • Visual acuity < 0.6
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients with Parkinson's DiseaseAlouette test (reading test)Patients with Parkinson's Disease (PD) were evaluated for reading disorders using a screening method validated for dyslexia.
Patients without Parkinson's Disease = control groupAlouette test (reading test)Patients without Parkinson's Disease (PD) were evaluated for reading disorders using a screening method validated for dyslexia.
Primary Outcome Measures
NameTimeMethod
Score on the Alouette test1 day

The Alouette test is based on the precision and speed in reading a short text (279 words). The score corresponds to the total number of words correctly read.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath